EverSource Wealth Advisors’s Mersana Therapeutics MRSN Stock Holding History

EverSource Wealth Advisors’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$318	–	4465
2025 Q4	$318	Sell	11 -3	-21%	-$57	﹤0.01%	3956
2025 Q3	$109	Sell	14 -206	-94%	-$1.55K	﹤0.01%	4188
2025 Q2	$1.63K	Buy	220 +112	+104%	+$984	﹤0.01%	3566
2025 Q1	$929	Buy	+108	New	+$1.67K	﹤0.01%	3256

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EverSource Wealth Advisors's MRSN Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 11 shares — an estimated $318 sold.

EverSource Wealth Advisors first reported a position in MRSN in Q1 2025 and held it in 4 quarters. The position peaked at $1.63K in Q2 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

EverSource Wealth Advisors reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 11 Mersana Therapeutics shares in Q1 2026, an estimated $318.
EverSource Wealth Advisors first reported a position in Mersana Therapeutics in Q1 2025 and held it in 4 quarters.
EverSource Wealth Advisors's Mersana Therapeutics position peaked at $1.63K in Q2 2025.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.